Consolidated Clinical trials

Pittsburgh, Pennsylvania 15221

0 studies enrolling now · 5 studies all time

What they study most

Chronic Shift Work Sleep Disorder, Excessive Daytime Sleepiness, Narcolepsy, Non-24-Hour Sleep-Wake Disorder, Obstructive Sleep Apnea/Hypopnea Syndrome

Studies at this site

• Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception — Completed
• Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder — Completed
• Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder — Completed
• Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness — Completed
• Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL — Completed